Literature DB >> 17329832

Cochinin B, a novel ribosome-inactivating protein from the seeds of Momordica cochinchinensis.

Juthamas Chuethong1, Kohei Oda, Hiroaki Sakurai, Ikuo Saiki, Wichet Leelamanit.   

Abstract

Cochinin B, a novel ribosome-inactivating protein (RIP) with a molecular weight of 28 kDa, was purified from the seeds of Momordica cochinchinensis (Cucurbitaceae). The isolation procedure entailed ammonium sulfate precipitation, cation-exchange chromatography on SP Sepharose column and size-exclusion chromatography on Superdex 75 column with a fast protein liquid chromatography (FPLC) system. The first twenty N-terminal amino acid residues of Cochinin B showed homology to type I RIPs from other Momordica species. The purified Cochinin B displayed a strong inhibitory activity on protein synthesis in the cell-free rabbit reticulocyte lysate system with IC50 of 0.36 nM. Furthermore, it exhibited N-glycosidase activity and cytotoxicity against Vero cell line with IC50 higher than 1540 nM. Interestingly, Cochinin B manifested strong anti-tumor activities on human cervical epithelial carcinoma (HeLa), human embryonic kidney (HEK293) and human small cell lung cancer (NCI-H187) cell lines with IC50 of 16.9, 114 and 574 nM, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329832     DOI: 10.1248/bpb.30.428

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

Review 1.  Ribosome-inactivating and related proteins.

Authors:  Joachim Schrot; Alexander Weng; Matthias F Melzig
Journal:  Toxins (Basel)       Date:  2015-05-08       Impact factor: 4.546

Review 2.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential.

Authors:  Kam Lok Wong; Ricky Ngok Shun Wong; Liang Zhang; Wing Keung Liu; Tzi Bun Ng; Pang Chui Shaw; Philip Chi Lip Kwok; Yau Ming Lai; Zhang Jin Zhang; Yanbo Zhang; Yao Tong; Ho-Pan Cheung; Jia Lu; Stephen Cho Wing Sze
Journal:  Chin Med       Date:  2014-07-19       Impact factor: 5.455

Review 4.  A Potential Anti-Tumor Herb Bred in a Tropical Fruit: Insight into the Chemical Components and Pharmacological Effects of Momordicae Semen.

Authors:  Xiao-Rong Xu; Chuan-Hong Luo; Bo Cao; Run-Chun Xu; Fang Wang; Xi-Chuan Wei; Ting Zhang; Li Han; Ding-Kun Zhang
Journal:  Molecules       Date:  2019-10-31       Impact factor: 4.411

5.  Antiviral Protein of Momordica charantia L. Inhibits Different Subtypes of Influenza A.

Authors:  Viroj Pongthanapisith; Kazuyoshi Ikuta; Pilaipan Puthavathana; Wichet Leelamanit
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-09       Impact factor: 2.629

6.  Evaluation of direct antiviral activity of the Deva-5 herb formulation and extracts of five Asian plants against influenza A virus H3N8.

Authors:  Namsrai Oyuntsetseg; Maxim A Khasnatinov; Perenlei Molor-Erdene; Janchiv Oyunbileg; Aleksander V Liapunov; Galina A Danchinova; Sanduijav Oldokh; Jigden Baigalmaa; Chimedtseren Chimedragchaa
Journal:  BMC Complement Altern Med       Date:  2014-07-10       Impact factor: 3.659

Review 7.  Which Plant Proteins Are Involved in Antiviral Defense? Review on In Vivo and In Vitro Activities of Selected Plant Proteins against Viruses.

Authors:  Oskar Musidlak; Robert Nawrot; Anna Goździcka-Józefiak
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.